Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
According to an article published today in The Boston Globe, the Dana-Farber Cancer Center and Brigham and Women’s Hospital are working together to initiate development of a very large, cancer-specific, genetic and clinical database.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Brigham and Women's, clinical, Dana-Farber, database, genetic, tumor | Leave a Comment »
A report just published on line in Nature Medicine describes the first use of intraoperative, tumor-specific fluorescence imaging to highlight the precise position of small groups of cancer cells in women with ovarian cancer, thereby allowing the surgeon to carefully excise such small groups of cells.
Filed under: Management, Treatment | Tagged: cells, excision, fluorescence, imaging, surgery, tumor | Leave a Comment »
A new review by Epstein, currently available on line in the Journal of Urology, provides a detailed analysis of the clinical significance of various factors in determining prognostic risk for newly diagnosed and recently treated patients with localized prostate cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biopsy, clinical, core, pathologic, prognosis, quantification, stage, T2, tumor, volume | 10 Comments »
An interesting new report from the research team at Memorial Sloan-Kettering Cancer Center has explored the relationship between the patterns of occurrence of positive lymph nodes (LNs) and the topography of the cancer in the prostate and the seminal vesicles.
Filed under: Management, Treatment | Tagged: lymph nodes, pathology, pattern, topography, tumor | Leave a Comment »
A research team at the University of Miami has come up with an innovative new method that (please note the emphasis) might offer a completely new way to eliminate remaining cancer cells in patients with prostate and other types of cancer after first-line therapy.
Filed under: Drugs in development | Tagged: antigen, cancer cell, expression, immunity, tumor | Leave a Comment »
Recent reports have addressed the following issues related to prostate cancer: How many biopsy cores is the right number? How “open” surgeons have adapted to laparoscopic surgery Hypoxia, the tumor environment, and how it affects treatment Gefitinib + radiation therapy in intermediate- and high-risk prostate cancer Fractures, prostate cancer, and androgen deprivation
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: ADT, androgen deprivation therapy, biopsy, fractures, gefitinib, hypoxia, Iressa, microenvironment, radical prostatectomy, tumor | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site